Agoracom Blog Home

Posts Tagged ‘Hemp’

North Bud Farms Inc. $NBUD.ca – Feds issue regs on #cannabis #edibles, beverages, extracts and topicals $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:32 PM on Wednesday, June 19th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE

—————

Feds issue regs on cannabis edibles, beverages, extracts and topicals

• THC content in edibles products will be limited to 10 milligrams per package;

• THC in concentrates and topicals will be limited to 1,000 milligrams; 

by Lisa Campbell

Edibles, beverages, extracts and topicals – oh my! Health Canada has finally released regulations guiding the production and sale of the next wave of cannabis products entering the legal market.

What we know so far: 

• THC content in edibles products will be limited to 10 milligrams per package;

• THC in concentrates and topicals will be limited to 1,000 milligrams; 

• Almost all of the products you know and love from the grey market will be available, from brownies and gummies to shatter and rosin; 

• Under the new regs, edible cannabis products cannot be produced in the same site as other food products nor can they be appealing to children.

The marketing of these cannabis products will continue to follow tobacco standards, although the warning labels will be focused more on harm reduction. Health Canada wants cannabis consumers to “start low and go slow” with so many cannabis products coming onto the market.

While cannabis consumers may hem and haw about the restrictive THC limit for edibles, restaurant owners across Canada are salivating at the prospect of finally being legally able to serve cannabis products regulated by Health Canada, only the federal government does not have the power to license on-premises sales. That power rests with the provinces. In Ontario, that would mean both the Ministry of Finance and the Ministry of the Attorney General handing down that responsibility to the Alcohol and Gaming Commission of Ontario to create a licensing regime.

The province has been fairly quiet on the issue of on-premises sales to date.

Despite the silence, DineSafe, the city’s food safety program, and Toronto Municipal Licensing & Standards have been exploring the possibility of allowing the sale of non-smokable cannabis products in cafés, restaurants and lounges. 

While the vaping and smoking of cannabis products on premises in Ontario is prohibited by the Smoke-Free Ontario Act, the only thing stopping restaurants from serving cannabis products is provincial licensing.  

Ontario Premier Doug Ford has told industry types privately that he would like Ontario to have the most permissive edibles regulations in Canada.

But cannabis smoking lounges seem like a pipe dream, with current regs prohibiting the sale of booze and cannabis in the same location. It’s up to the province of Ontario to move forward to allow the sale. Nova Scotia has done it.

But complicating matters is the fact that the Legislature is on summer recess and won’t be back to the daily business of governing until late October, which is after the new regs are scheduled to come into effect October 17. 

Without on-premises sales, this leaves a huge grey area for cannabis events, live concerts and edibles dinners.

Many questions remain as to how on-premise sales will roll out across Canada.

Lisa Campbell is CEO of Lifford Cannabis Solutions and co-chair of the Cannabis Beverage Producers Alliance.

Source: https://nowtoronto.com/news/cannabis-edibles-are-here/

North Bud Farms $NBUD.ca Signs Binding Letter of Intent to Acquire California Licensed Extraction Company Tanforan Ventures $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 11:39 AM on Tuesday, June 18th, 2019
Northbud large
  • Entered into a binding letter of intent to acquire all of the issued and outstanding securities of Tanforan Ventures LLC, a California-based licensed operator holding Category 7 extraction and distribution licenses, in a transaction valued at CAD$8.6 million
  • Tanforan holds manufacturing and distribution licenses in the state of California and is in the final stages of completing its new Category 7 licensed extraction facility in Woodland, California 

TORONTO, June 18, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce that effective June 15, 2019 it has entered into a binding letter of intent (“LOI”) to acquire all of the issued and outstanding securities of Tanforan Ventures LLC (“Tanforan”), a California-based licensed operator holding Category 7 extraction and distribution licenses, in a transaction valued at CAD$8.6 million.  

Tanforan holds manufacturing and distribution licenses in the state of California and is in the final stages of completing its new Category 7 licensed extraction facility in Woodland, California.

“We are very excited to have the opportunity to secure additional infrastructure and talent as we continue to execute on our U.S. expansion plans,” said Ryan Brown, CEO of North Bud Farms. “This strategically located extraction facility will facilitate the transportation of crude extract derived from bio-mass grown at contract farms located in Northern California. Assuming the successful closing of the proposed transaction with Tanforan and our previously announced transaction with Eureka Vapor, we intend to further process the crude extract into a finished consumer product at Eureka Vapor’s manufacturing and distribution facility located in Los Angeles to service the Southern California market.”
                                   
Transaction Terms
The proposed transaction (the “Transaction”) is currently structured as a share purchase agreement whereby in exchange for the purchase of all of the securities of Tanforan, NORTHBUD will issue CAD$5 million in common shares (“Common Shares”) to the shareholders of Tanforan (the “Tanforan Shareholders”) with the price per Common Share to be determined based on a formula of the higher of (a) CAD$0.35 per Common Share and (b) the 30-day volume weighted average price (“VWAP”) calculated on the closing date (the “Closing Date”) of a definitive agreement in respect of the Transaction (the “Definitive Agreement”).  NORTHBUD and Tanforan expect to enter into the Definitive Agreement by October 1, 2019.

In addition, Tanforan shareholders will be entitled to receive up to an additional CAD$3.6 million in Common Shares of NORTHBUD, on a pro rata basis, upon Tanforan achieving revenue of USD$11,700,000 from extraction contracts over a 12 month period following the closing of the Transaction.  All of the foregoing revenue milestone Common Shares will have a deemed value equal to the consideration shares and will be subject to the same escrow period.

10% of the Common Shares to be issued pursuant to the Definitive Agreement will be issued to the Tanforan shareholders on the Closing Date, with the remainder of the Common Shares to be issued in equal tranches after six, twelve, eighteen, and twenty-four months from the Closing Date (the “Escrow Period”). 

The Transaction is a significant acquisition, but will not result in a “Fundamental Change” pursuant to the policies of the CSE. NORTHBUD will be preparing the necessary corporate and securities filings in order to secure the required approvals for the Transaction.

NORTHBUD has agreed to pay $150,000 in broker/finder fees to arm’s length parties in connection with the closing of the Transaction.

The closing of the Transaction is conditional on Tanforan receiving its final Certificate of Occupancy from the city of Woodland, the receipt of all applicable permits as well as the receipt by the parties of applicable corporate and regulatory approvals including that of the CSE.

“The opportunity to acquire a state-of-the-art facility with an experienced operations team is an exciting prospect for NORTHBUD,” says Ryan Brown, CEO of NORTHBUD. “We believe that the combination of Tanforan’s facility and services combined with Eureka Vapor’s products and distribution will give NORTHBUD an excellent platform to capitalize on the California recreational cannabis market, considered to be the largest in North America.” 

“The Tanforan team is excited to join forces with NORTHBUD and Eureka to capitalize on the largest consumer market in North America,” said Shannan Day, CEO of Tanforan Ventures. “Tanforan has extensive exclusive agreements with licensed Cannabis farms in Northern California and we look forward to working with NORTHBUD and Eureka to create high quality products for distribution in Southern California.”

While the proposed transactions involving Tanforan and Eureka Vapor are complementary, they are independent and the Company may ultimately proceed to close one, both or neither of the proposed transactions, depending on market conditions and regulatory requirements.

Update on Acquisition of Eureka Vapor
As previously announced in the Company’s press release dated May 15, 2019, NORTHBUD and Eureka Vapor LLC (“Eureka”) continue to work towards completing a definitive agreement whereby NORTHBUD is to acquire all of the issued and outstanding shares of Eureka and all of its subsidiaries. Based on projected timelines for the completion of the audit of Eureka’s financial statements, the companies expect to sign a definitive agreement in the third quarter of the 2019 calendar year.

Update on Financing
The Company expects to close a first tranche of its non-brokered private placement later this week. As previously announced on May 15, 2019, the private placement is for up to 13,333,333 units at a price of $0.30 per unit, for gross proceeds of up to $4 million. Each unit will be comprised of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to acquire an additional share at a price of $0.40 for a period of 24 months from the closing date. 

About Tanforan Ventures LLC.
Historically Tanforan’s business operated under the proposition 215 regulatory structure. As of January 2019, Tanforan successfully applied for and received a volatile extraction license under the California adult use regulations laws. Tanforan specializes in white label extraction services.

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

About Eureka Vapor LLC
Headquartered in Los Angeles, California, EUREKA Vapor was founded in 2011 and holds licenses in both California and Colorado.  EUREKA Vapor’s multi state operation manufactures and sells a premium line of vaporizer cartridges, disposable vapor pens and proprietary vaporizer batteries designed to work with their highly sought-after CO2 extracted oil.  Using their refined extraction processes and techniques developed over almost a decade of extracting, EUREKA Vapor is committed to providing the cleanest and safest natural oil cartridges in the industry.  Long referred to as one of the leaders in the industry, EUREKA has one of the most loyal customer bases in the category which reflects their commitment to honesty and transparency above all else. EUREKA continually looks for innovative ways to improve and refine their product offerings in order to deliver the best, most consistent vaping experience in the industry. 

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements including those relating to the  entering into of the Definitive Agreement, closing of the Transaction and associated approvals, Tanforan’s ability to achieve milestones under the Definitive Agreement and associated Common Share issuances. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Marijuana Company of America $MCOA and Joint Venture Partner Global Hemp Group Announce Start of Commercial Planting at Hemp Farm $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:37 AM on Tuesday, June 18th, 2019
15233 mcoa
  • Announced the start of its commercial planting at its hemp farm in Scio, Oregon.
  • Also in the process of obtaining organic certification
  • This season’s harvest was more environmentally friendly, with biodegradable plastic mulch brought in from Canada to eliminate the end-of-season environmental waste, thus reducing labor costs associated with its removal from the field.

ESCONDIDO, Calif., June 18, 2019 – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, along with joint venture partner Global Hemp Group (CSE: GHG/ OTC: GBHPF/ FRA: GHG), are pleased to announce the start of its commercial planting at its hemp farm in Scio, Oregon.

Marijuana Company of America previously announced its high-yielding cannabidiol (CBD) hemp farming project with joint venture partner Global Hemp Group in 2018. The Scio, Oregon, farm, operating under the name Covered Bridge Acres Ltd. (“CBA”), has finished preparing the 35-acre land for planting, which is now in the process of laying the last of the mulch and drip line. CBA is also in the process of obtaining organic certification. This season’s harvest was more environmentally friendly, with biodegradable plastic mulch brought in from Canada to eliminate the end-of-season environmental waste, thus reducing labor costs associated with its removal from the field.

The hemp plants used for this year’s cultivation have been produced from either sprouted seed or through CBA’s cloning operation that is done onsite at the Company’s greenhouses fully controlled by the CBA team. Genetics being used this year are of higher quality and more stable than those planted last year. The team expects to plant 40,000 to 50,000 plantlets this year, with a CBD content ranging from 12 percent to 15 percent. Any excess clones not required for the field will be sold or used for expansion. This year’s cloning operation has eliminated the need to purchase clones from third parties, as was required last season. This will reduce operating expenses in the current year by approximately $200,000.

The CBA team continues to prepare the greenhouses for constant harvest to produce high-quality, smokeable hemp flower. Trimmed, high-end flower, with less than 0.3 percent THC, currently wholesales for 10 times the price of CBD biomass that is going to extraction.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN, and CBC) and creating a near-term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward-looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362

Corporate Communications Contact: 
NetworkWire (NNW)
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
[email protected] 

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

New #Hemp Energy Drink to be offered to consumers in #cannabis accessory stores, #vapes stores, and kiosks in Canada and the US #Spyder $SPDR.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:28 AM on Tuesday, June 18th, 2019
Spdr logo large
  • Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) to distribute the three flavors of its Hemp Energy Drink in cannabis accessory stores and vapes stores in Canada and the US
  • Drink is expected to be available to consumers in Spyder’s retail stores located in Scarborough, Woodbridge, Burlington, and shortly at the Niagara Falls and Pickering locations, which are expected to be opened early this summer.

OTTAWA, June 18, 2019 — Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) (“Spyder”) to distribute the three flavors of its Hemp Energy Drink in cannabis accessory stores and vapes stores in Canada and the US. The drink is expected to be available to consumers in Spyder’s retail stores located in Scarborough, Woodbridge, Burlington, and shortly at the Niagara Falls and Pickering locations, which are expected to be opened early this summer. A launch event will be held during the Canada Day long weekend at the Niagara Falls location situated at 6474 Lundys Lane.

“We are very excited to be adding the Hemp Energy Drink to our portfolio of premium brands that will be available to our growing clientele,” stated Daniel Pelchovitz, CEO and President of Spyder. “This new offering will please our customers who are always seeking unique and distinctive quality products in this emerging industry.” 

“This exclusive agreement allows us to take another step in implementing our distribution strategy and achieving our goal of making our Hemp Energy Drink accessible to all consumers â€œ said Richard Giguère, CEO of Tetra Natural Health “Consumers appreciate the qualities of the Hemp Energy Drink (HED) including the fact that it contains more natural ingredients than other energy drinks, and is the first energy drink made with hemp available in the country” adds Derek Theriault, National Sales Director of Tetra Natural Health.

About Tetra Natural Health:
Tetra Natural Health Inc. is a subsidiary of Tetra Bio-Pharma Inc. that focuses on identification, development and marketing of hemp or cannabis-based natural health products, or cannabinoids-based products authorized for sale by Health Canada. For more information, visit: www.tetranaturalhealth.com

About Spyder Cannabis Inc.
Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis market. Spyder has developed a scalable retail model with an aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian locations in high traffic peripheral areas.

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved and FDA reviewed clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Tetra Bio-Pharma has subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of its mission, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.


More information at: www.tetrabiopharma.com

For more information, please contact:
Tetra Natural Health
Richard Giguère, CEO
Tel.: (348) 899-7575 ext. 210
[email protected]

Spyder Cannabis Inc.
Dan Pelchovitz, President and CEO
Tel: (905) 265-8273
[email protected]


For TBP investors information, please contact:
[email protected]
(438) 504-5784

Media Contacts – Tetra Natural Health
Daniel Granger
ACJ Communication
W. 514 840-7990
M. 514 232-1556
[email protected]

Charlotte Blanche
W. 514 840-1235, ext. 7772
M. 514 914-0593
[email protected]


A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/267699bb-2f70-4744-8ecf-26cf47464a9c

Hemp Energy Drink (3 flavors)

Hemp Energy Drink (classic, mango and raspberry)

Source: GlobeNewswire (June 18, 2019 – 8:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

Empower Clinics $CBDT.ca Launches Sun Valley Health and National Franchise Program $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 7:15 AM on Tuesday, June 18th, 2019
Epw logo1
  • Announced the launch of new clinic brand Sun Valley Health and the launch of a nationwide clinic franchise program. http://www.sunvalleyhealth.com
  • Company is consolidating its clinic operations under one consistent brand, merging the existing clinic operations of Sun Valley Clinics in Arizona and Nevada, plus the existing physical and mobile clinic operations of Empower Clinics in Washington State and Oregon State

VANCOUVER, June 18, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to announce the launch of our new clinic brand Sun Valley Health and the launch of a nationwide clinic franchise program. http://www.sunvalleyhealth.com

The Company is consolidating its clinic operations under one consistent brand, merging the existing clinic operations of Sun Valley Clinics in Arizona and Nevada, plus the existing physical and mobile clinic operations of Empower Clinics in Washington State and Oregon State. All Company clinics will commence operating under Sun Valley Health, with the updated brand changes coming into effect immediately.

The Company is also announcing the official launch of the Sun Valley Health franchise program. With the 2019 Franchise Disclosure Document (FDD) ready to deploy and the 2019 franchise audit completed, the Company will be in a position to accept applications for a Sun Valley Health franchise throughout the United States.

Investment has already been made in developing a new trade show booth, plus new franchise sales & marketing material that will be utilized to showcase the franchise opportunity at industry specific and franchise trade shows throughout North America. The new website is live and will continue to be developed, adding content and features for patients, consumers and prospective franchisees.

Nine (9) trade shows have already been booked over the next nine months, with the first show taking place in St. Louis, MO July 23rd & 24th, 2019. Look for us at booth #144 at https://www.cannabisimp.com/st-louis-expo/

“At Sun Valley Health, we’ve taken the once cumbersome process of obtaining lab tested, all natural CBD and health supplements, into a clinical professional experience.” said Dustin Klein, Empowers SVP, Business Development and Director. “We provide alternative health modalities and products backed by science, that pass our rigorous standards of quality and effectiveness.”

HIGHLIGHTS

  • Scientific Approach to Alternative Medicine Having access to physicians that understand qualifying conditions of patients is a primary focus of our entire team. Care for each individual’s circumstance and need guides our staff protocols on privacy, care and treatment options.
  • Know What’s in your Product The products offered to our patients in clinics and online, go though rigorous testing standards by independent labs to ensure, what’s represented on the label is correct.

“Knowing what’s in your product is about trust, and professionalism counts, standards count and testing counts,” said Steven McAuley, CEO of Empower. “Our Sollievo product line and any product line that we choose to include in our clinic kiosks, online or are offered through franchise operations, will be subject to testing and must meet the highest of standards.”

ABOUT EMPOWER

Empower is a leading multi-state operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. Operating as a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company can produce and package its proprietary line of cannabidiol (CBD) based products and distribute through company owned and franchised clinics, with wholesale partnerships, online and with retailers nationwide.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; access to Empower’s home delivery and e-commerce platform; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operation by Q2 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2019/18/c6532.html

CONTACTS: Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019

Bougainville Ventures $BOG.ca and ESEV R&D Begins Formulation Process for CBD Energy Drink $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 8:41 AM on Thursday, June 13th, 2019
681747 5720 copy 2
  • Further to the Israeli sponsorship research agreement announced in the Company’s news release dated May 14, 2019, management is pleased to announce that it has paid a 10% deposit to ESEV R&D to begin the formulations process on the water soluble cannabis-based (CBD) supplement energy drink
  • The final report will include; clinical trials results, sourcing of ingredients, PH balance, nutritional chart, shelf-life, as well as cost of ingredients and contacts.

VANCOUVER, British Columbia, June 13, 2019 – BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG) (Frankfurt:8BV)Further to the Israeli sponsorship research agreement announced in the Company’s news release dated May 14, 2019, management is pleased to announce that it has paid a 10% deposit to ESEV R&D to begin the formulations process on the water soluble cannabis-based (CBD) supplement energy drink. The final report will include; clinical trials results, sourcing of ingredients, PH balance, nutritional chart, shelf-life, as well as cost of ingredients and contacts.

Andy Jagpal, President, Comments:“We have already begun sourcing a local bottling company to handle the production and processing of the CBD energy drink once the formulations are ready. We are adamant about bringing the energy drink formulation to market and feel we have developed the right relationships to get the job done right.”

WORMCASTING TRANSACTION FINANCING UPDATE

Further to the Company news release dated June 11, 2019, management is pleased to announce that it has paid-off the final outstanding payment of USD$120,000 owed to Worm Castings Farms Inc. pursuant to Bougainville’s obligation under the Worm Castings Share Exchange Agreement.

OROVILLE CAMPUS UPDATE

Further to the Company news release dated April 1, 2019, management would like to announce that the tenant grower is waiting to receive final occupancy approval from the Washington State Liquor and Cannabis Board (“WSLCB”) to begin planting. The tenant expects a visit to the site by the WSLC in the near future and is planning to plant a 20,000 sq. ft. out-door crop.

In addition, the Company wishes to correct an error in its news release dated May 1, 2019 in which the Company announced that a private placement with gross proceeds of $190,000 for 3,166,666 Units at a price of $0.06 per Unit (the “Private Placement”) had closed. The Private Placement was oversubscribed for 3,316,666. The remainder of the news release dated May 1, 2019 is accurate and the oversubscribed Private Placement was closed on May 1, 2019 with the amount of $199,000 for 3,316,666 Units

About Bougainville Ventures, Inc.  
Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids (CBD & CBN) in both Canada and the United States. With our flagship Hemp project in Oregon State the Company has proprietary, patent-pending hemp root oil extraction technology and formulas for cannabis topicals and tinctures.

http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-888-395-7816 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Empower Clinics $CBDT.ca Provides Corporate Update and Announces New Board Member $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 7:12 AM on Thursday, June 13th, 2019
Epw logo1
  • Company continues to reach a number of important milestones on its path forward, as a global health and wellness company, serving the needs of patients through its network of physician-staffed health and pain management clinics, formulating CBD based products and developing its first CBD extraction facility

VANCOUVER, June 13, 2019  – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to provide an update on recent corporate activities and Director changes.

The Company continues to reach a number of important milestones on its path forward, as a global health and wellness company, serving the needs of patients through its network of physician-staffed health and pain management clinics, formulating CBD based products and developing its first CBD extraction facility.

HIGHLIGHTS

  • Takes Possession of CBD Extraction Facility As previously announced, the Company has taken possession of its new facility in greater Portland, Oregon that will be home to a fully functioning hemp-based CBD extraction facility, with the first extraction system expected to have the capacity to produce 6,000 kilograms of extracted product per year. The facility is expected to provide Empower with vertical integration into the CBD supply chain, producing isolates, distillates and winterized oil that are showing strong demand in local and national markets. The Company has commenced preliminary build-out starting with IT and technology implementations plus security system installations.

  • Engages Leading Architect Firm Empower has engaged Pathangay Architects www.pathangayarchitects.com of Phoenix, AZ lead by Navin Pathangay as the lead architect firm for the build-out of the first company extraction facility. Navin Architects are one of the leading Cannabis industry architects having worked on numerous industry projects including dispensaries, medical clinics, grow operations and extraction facilities.

  • Integration of Sun Valley Clinics The Sun Valley Clinics acquisition is providing productivity gains and in-market expertise that is accretive to our clinic division. Official operational integration is fully underway, with the best practices of Sun Valley and Empower are coming together to create world-class clinic operations. The operations team at Sun Valley has assumed key administrative tasks on behalf of the Empower network of clinics including bookkeeping, human resources, payroll and day-to-day accounts payable and accounts receivable tasks.

We expect to drive further productivity by eliminating duplicate and/or redundant information technology systems and by brining campaign marketing programs such as text messaging, email and call center functions under the Sun Valley operations, to improve effectiveness and reduce costs.

The current Sun Valley clinic locations are as follows:

4218 W Dunlap Ave, Phoenix, AZ
12801 W Bell Rd #145, Surprise, AZ
4015 E Bell Rd #130, Phoenix, AZ
2011 E University Dr, Mesa, AZ
7074 E Speedway Blvd, Tucson, AZ
2550 S Rainbow Blvd, Las Vegas, NV

  • Launches CBD Tincture Product Line Empower has commenced selling its proprietary line of CBD-based products called SOLLIEVO, through its network of company-owned clinics in the United States. The Sollievo tincture line includes four (4) preliminary SKU’s for chronic pain, insomnia, digestion and anxiety. Preliminary user feedback has been positive and third party lab test results have confirmed the ingredients and dosages of our proprietary formulations are consistent with what is indicated on the labels and packaging. Empower’s patient base and customers are expected to benefit from access to high margin derivative products, including CBD lotion, tinctures, spectrum oils, capsules, lozenges, patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet elixir hemp extract drops.

  • CBD Market Demand The passing in the United States of the US$867 billion Agriculture Improvement Act (the “Farm Bill“) has legalized hemp and hemp-based products. This has created an opportunity for the production and sale of a variety of CBD-based products that can provide genuine help and effective relief to millions of people suffering from a variety of qualifying conditions. Recent reports and studies indicate the approval of the Farm Bill could create a US$20 billion industry by 2022.

“With the closing of the Sun Valley Clinics acquisition behind us, we are already seeing such positive impact with integration and the development of our overall company culture,” said Steven McAuley, CEO of Empower. “By adding the extra resources to our company, we have much more capacity grow and execute on the various initiatives I have announced previously.”

Appointment of New Board Member

The Company is also pleased to announce the appointment of Mr. Andrejs Bunkse as a Director of the company, effective as of May 26, 2019.  Mr. Bunkse is a graduate of Syracuse University and holds a Juris Doctorate from Santa Clara University School of Law. As the owner and practicing attorney of Rain Legal and partner in Nimbus Legal, Andy brings industry specific expertise and deep connections to major industry players plus the investment banking and Family office community.

“We are so honored to have Andy Bunkse join our Board, to play an active role in supporting our next phase of growth and development”, said Steven McAuley, CEO of Empower.  “His substantial negotiating and deal structuring experience along with industry ties and reputation, adds tremendous pedigree to our leadership team.”

The Company also announces the resignation of Peter McDonough as a Director effective May 24th, 2019. We would like to thank Peter for his contributions.

ABOUT EMPOWER

Empower is a leading multi-state operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. Operating as a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company can produce and package its proprietary line of cannabidiol (CBD) based products and distribute through company owned and franchised clinics, with wholesale partnerships, online and with retailers nationwide.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; access to Empower’s home delivery and e-commerce platform; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operation by Q2 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2019/13/c2381.html

Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019


Source: Canada Newswire (June 13, 2019 – 6:00 AM EDT)

Spyder Cannabis $SPDR.ca Announces Upcoming Opening of Additional Retail Locations and Launch of SPDR Website $META $N $NXTTF $WEED

Posted by AGORACOM-JC at 9:12 AM on Tuesday, June 11th, 2019
Spyder
  • Will be opening an additional two retail stores within the next month, for a total of 5 locations, and the upcoming launch of its proprietary SPDR website
  • Commences trading today on the TSX Venture Exchange,
  • Under phase one of the Turn-Key Strategy, Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products
  • Under phase two of the Turn-Key Strategy, Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity

Vaughan, Ontario–(June 11, 2019) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“), an established Ontario retail operator, is pleased to announce that it will be opening an additional two retail stores within the next month (the “New Retail Locations“), for a total of 5 locations, and the upcoming launch of its proprietary SPDR website (the “SPDR Website“). The Company, which commences trading today on the TSX Venture Exchange, believes that the Retail Locations and the SDPR Website are a valuable part of its North American retail and e-commerce wellness growth strategy.

Retail Locations

The Company will open the New Retail Locations within the next month, which will be located in Niagara Falls at 6474 Lundys Lane (the “Lundys Lane Location“) and in Pickering at 776 Liverpool Road, Unit 4. The New Retail Locations will, initially, focus on the sale of cannabis accessories, hemp seed oil products, and hemp accessories.

The Lundys Lane Location, two other retail locations that Spyder operates in Burlington and Calgary and a location that it intends to open in Guelph, subject to negotiating satisfactory terms with the landlord, will all be converted into cannabis retail stores as part of the Company’s “Cannabis Turn-Key Strategy” (the “Turn-Key Strategy“). Under phase one of the Turn-Key Strategy, Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products. Under phase two of the Turn-Key Strategy, Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity. The Company believes this strategy will allow it to generate stable revenue streams during the interim period before the stores receive a retail cannabis licence, and will allow the Company to swiftly pivot into the sale of cannabis products once appropriate licences have been received.

SPDR Website

The Company expects to launch the SPDR Website by July 1, 2019. The SPDR Website is currently in an advanced stage of development, and will focus on selling cannabis accessories and a variety of hemp-based products on a retail and wholesale basis within Canada. The Company intends to focus on offering its own SPDRTM branded products, which are made up of a number top-of-the line and unique products, along with leveraging the Company’s deep knowledge of the retail industry to offer a number of other best-in-class products that it has identified over the years.

“Spyder is excited to be able to announce our pending opening of two additional retail locations within Ontario, bringing our total to 5 operating stores and the launch of the SPDR website, which we believe demonstrate our commitment to creating value for our shareholders, a responsibility we take seriously as a newly listed company. We recently promised that we would take tangible steps to benefit our shareholders, and we believe that these latest developments leave us headed in the right direction,” said Dan Pelchovitz, Chief Executive Officer and President of Spyder.

About Spyder

Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis market. Spyder has developed a scalable retail model with aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian locations in high traffic peripheral areas.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. In particular, this news release contains forward looking statements regarding, without limitation: Spyder’s anticipated roll-out of the New Retail Locations and the SPDR Website in the timelines indicated or at all, the receipt by Spyder of cannabis licences on the timelines indicated or at all, and the products that Spyder plans to offer at the New Retail Locations and the SPDR Website.

Bougainville Ventures Inc. $BOG.ca Enters in to Funding and Asset Purchase Agreement with Island Biopharma Inc. $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:18 AM on Tuesday, June 11th, 2019
681747 5720 copy 2
  • Signed a letter of intent (LOI) to provide funding and to acquire 100% of the assets and inventory of Island Biopharma Inc.
  • Biopharma has developed a dedicated line of Cannabidiols products which a include proprietary CBD blended tincture product with three specific recipes for anxiety, energy and sleep.

VANCOUVER, British Columbia, June 11, 2019 — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG) is pleased to announce that it has signed a letter of intent (LOI) to provide funding and to acquire 100% of the assets and inventory of Island Biopharma Inc.(Biopharma). Biopharma has developed a dedicated line of Cannabidiols (“CBD”) products which a include proprietary CBD blended tincture product with three specific recipes for anxiety, energy and sleep.

LOI Terms

Subject to Board approval from the Company and completion of satisfactory due diligence, the parties intend to enter into a definitive agreement on or before June 30, 2019. The Company will acquire 100% of Biopharma assets and current inventory. The consideration is to be payable in such number of common shares in its share capital (“Consideration Shares”) at a per share price equal to the volume weighted average price of such shares on the Canadian Securities Exchange over a 15-day period ending on the day such Consideration Shares are required to be issued (“15 day VWAP”). In addition, Biopharma will contribute operational expertise, exclusive licenses for products marketed in North America supported by an intellectual property licensing agreement, and exclusivity for all current and future technology for oil extraction in North America. The final evaluation will be determined by an independent third party evaluator, which is currently in progress.

Assets include:

  • Proprietary Formulas for Anxiety, Energy and Sleep
  • Lab Reports
  • All Proprietary Information

About Island Biopharma Inc.

Biopharma possesses a CBD blended tincture product with three specific recipes for anxiety, energy and sleep. The philosophy of Biopharma is to create products using the highest quality of bio-active ingredients, and oil extraction methods that preserve the essence of the cannabis plant. Biopharma has studied plant genetics for their therapeutic effects by incorporating modern research techniques and by analyzing the healing and therapeutic benefits of each strain giving the company a huge range of combinations and therapeutic benefits for specific ailments.

According to an estimate from cannabis industry analysts the hemp-CBD market alone could hit $22 billion by 2022. CBD can be used to effectively treat epilepsy, anxiety, insomnia and chronic pain. The Island Biopharma CBD line is designed to harness the healing power of cannabis without the psychotropic effects of tetrahydrocannabinol (“THC”).

CEO, Andy Jagpal Comments: 
“This marks an exciting step forward for our brand’s expansion into multiple CBD products. The acquisition of Island Biopharma will contribute greatly to our future product lines. With the development of our CBD infused energy drink already in development this acquisition will complement our goal of producing high quality proven cannabaniod products. This is in-line with the anticipated launch of the Canadian cannabis legislation bringing about the legalization of the edible market slated for the fall of 2019”.  

WORMCASTING TRANSACTION FINANCING UPDATE

Further to the Form 45-102F1 Notice of Intention to Distribute Securities filed May 22, 2019 and associated news release dated May 24, 2019 the Company announces that management has sold a total of 1,000,000 shares of (BOG:CSE) with proceeds of $CAD100,000. These proceeds have been contributed towards the final outstanding payment of $USD120,000 owed to Worm Castings pursuant to Bougainville’s obligation under the Worm Castings Transaction announced in the Company’s news release dated May 23, 2019. Management continues to defer salaries as it has for the past two years to help conserve working capital to enable the company to reach its milestones.

About Bougainville Ventures, Inc.  
Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids (CBD & CBN) in both Canada and the United States. With our flagship Hemp project in Oregon State the Company has proprietary, patent-pending hemp root oil extraction technology and formulas for cannabis topicals and tinctures.

http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-844-734-8420 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release. Source: GlobeNewswire (June 11, 2019 – 3:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

INTERVIEW: Vertical Exploration $VERT Discusses Wollastonite Which Is Proving To Be a Critical Tool for Cannabis Crop Protection and Enhancement $TORR.ca $FA.ca

Posted by AGORACOM-JC at 9:43 AM on Monday, June 10th, 2019

Joining us on this episode is Peter P. Swistak, President/CEO of Vertical Exploration.

The company has recently received positive results from its Phase 1 Research and Development program that was conducted by AGRINOVA using wollastonite from the Company’s St-Onge deposit. All of the research and testing in the Phase 1 program was managed and monitored by AGRINOVA, a highly-regarded Center for Research and Innovation in Agriculture in Quebec, in an effort to optimize the potential agricultural uses of wollastonite and help improve production methods for farmers and agricultural companies located in Quebec.